Lip Cancer Clinical Trials and Average Enrollment by Top Countries - Ken Research
by Ashish Kumar Market ResearcherThe report titled “Lip Cancer
Global Clinical Trials Review H2 2017”, provides a comprehensive analysis of lip
cancer, causes, various treatments, Mohs micrographic surgery, leading players,
basics of clinical trials and phases, impact of lip cancer, modernization and
evolution in medical science will detect lip cancer at early stage in the
coming years.
Lip Cancer Overview: Lip cancer is disruptive growth of cells
which form injuries or tumors on the lips. Lip cancer is also known as the most
common type of oral cancer. It develop in thin, flat cells known as squamous
cells that line the lips, mouth, tongue, cheeks, sinuses, throat, and hard and
soft palates. Modern lifestyle choices, such as smoking, drinking, sun
exposure, and tanning, increase the risk of developing lip cancer. The first
signs of lip cancer are noticed by the dentists during any routine dental
examination. If diagnosed early lip cancers are highly curable. It was observed
that more than 36,000 people globally are diagnosed with oral cancer every
year.
Factors, Symptoms, Available
Treatments and Prevention of Lip Cancer: Major factors that increase the risk for lip
cancers include smoking or using tobacco products (cigarettes, cigars, pipes,
or chewing tobacco), heavy use of alcohol, exposure to direct sunlight (both
natural and artificial), including the use of tanning beds, over long periods,
infection with human papillomavirus (HPV), a sexually transmitted virus and
above 40 years of age as well as cases of immune-suppression. The symptoms of
lip cancers are sore, lesion, blister, ulcer, or lump on the mouth that does
not go away, a red or white patch on the lip, bleeding or pain on the lips and
swelling of the jaw. The various treatments available for lip cancer are
surgery, radiation therapy, chemotherapy, immunotherapy, cryotherapy (freezing
with liquid nitrogen) and gene therapy. The treatment depends on the stage of
the lip cancer and the size of the tumor. Surgery is performed to remove if it
is a small tumor. If the tumor is large or at a later stage, radiation and
chemotherapy treatments are used to shrink the tumor to reduce the risk of
re-ocurrence. Lip cancer can be prevented by avoiding all types of tobacco,
alcohol intake, and limiting exposure to both natural and artificial sunlight.
Mohs micrographic surgery is commonly used to
treat lip cancer which involves removing thin layers of skin tissue, which are
then colour-coded, mapped, and microscopically examined. If cancer cells are
detected, more tissue from the affected area is removed and the process is
repeated until no more cancer can be found. This surgery offers the highest
cure rate of any treatment modalities for primary or recurrent lip tumors.
Emergency treatment is recommended for cases where lip cancer has spread and is
known to interfere with the function of a vital organ. Men are at a greater
risk than women in occurrence of lip cancer. Lip cancer diagnostic tests
involve physical examination for sores, lumps or mouth ulcers. Biopsy, X-rays
and CT scans are also done to determine the spread of lip cancer. Other
diagnostic tests include endoscopy, exfoliative cytology, Magnetic Resonance
Imaging (MRI), barium swallow, PET scan and bone scan.
Geography and Leading Players in Lip
Cancer: To reduce the
risk of lip cancer, doctors prescribe regular use of photo protective lip blocks
(lip products that contain sunscreen) because they help reduce exposure to U.V.
radiation. Lip cancer market is geographically spread across North America,
Europe, Asia Pacific and Rest of the World. The Unites States ranks first in
lip cancer cases, followed by Asia-Pacific with considerable number of lip
cancer cases. The leading players in global lip cancer market are Astra Zeneca
plc, Bristol Myers Squibb, Celgene, Eli Lilly & Co., Hofmann La Roche,
Pfizer, Sanofi Aventis, Teva Pharmaceuticals, and Novartis AG.
Clinical Trials for Lip Cancer
Involves Four Phases:
Clinical trials are research studies that compare the most effective known
treatment for a specific type or stage of cancer with a new approach. It can be
a new drug, or combination of drugs or a different way of using the already
established therapies. There are clinical trials for every type of cancer, to
prevent cancer, improve early diagnosis, stop the cancer from coming back,
reduce side effects or improve quality of life.
The first phase is where the drug is approved
for human consumption and is tested in a small trial to determine the optimal
safe dose which often involves patients with different kinds of cancer. In
second phase, the approved drug is tested on cases with multiple cancers to
determine the optimal dosing and provide an early assessment of whether the
drug works. The third phase involves hundreds, or even thousands of patients,
in multiple centres with specific types and stages of cancer. This stage
provides definitive evidence to support the approval of the drug for use in the
public. The phase four is known as post-marketing trials where the goal is to
make sure that no safety or other concerns come up after a drug is approved
that may not have been seen in the pre-approval trials.
Future of Global Lip Cancer Clinical
Trials: It was observed
that lip cancer clinical trials are collated from 80 plus different clinical
trial registries, conferences, journals, news, etc across the globe. The lip
cancer clinical trials database undergoes periodic update. Lip cancer is not
only claiming lives but has a huge impact on the global economy. It also
highlights the urgency of tackling preventable cancers globally. With
increasing modernization and evolution in medical science, lip cancer is
expected to be treated at an early stage with less pain and cost over the
coming years.
Key Topics Covered in the Report:
Global Lip Cancer Clinical Trials Market
Research Report
Global Lip Cancer Clinical Trials Market Size
Global Lip Cancer Clinical Trials Market
Outlook
Global Lip Cancer Clinical Trials Market
Forecast
Cancer industry clinical Trials
Global Lip Cancer Clinical Trials Market
Analysis
Central Lip Cancer Therapeutics Clinical
Trials
Europe Lip Cancer Therapeutics Clinical Trials
North America Lip Cancer Therapeutics Clinical
Trials
Middle East Lip Cancer Therapeutics Clinical
Trials
Asia Lip Cancer Therapeutics Clinical Trials
Lip Cancer Clinical Trials and Average
Enrollment by Top Countries
South America Lip Cancer Therapeutics Clinical
Trials
To know more, click on the link below:
To review related reports, click on
the links below
Contact:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91-124-4230204
Sponsor Ads
Created on Feb 9th 2018 06:12. Viewed 353 times.